Comparative outcomes and toxicities for ruthenium-106 versus palladium-103 in the treatment of choroidal melanoma.

about

Comparative outcomes and toxicities for ruthenium-106 versus palladium-103 in the treatment of choroidal melanoma.

Item

http://www.wikidata.org/entity/Q47179566

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Comparative outcomes and toxic ...... eatment of choroidal melanoma.

@en

Comparative outcomes and toxic ...... eatment of choroidal melanoma.

@nl

type

Item

label

Comparative outcomes and toxic ...... eatment of choroidal melanoma.

@en

Comparative outcomes and toxic ...... eatment of choroidal melanoma.

@nl

prefLabel

Comparative outcomes and toxic ...... eatment of choroidal melanoma.

@en

Comparative outcomes and toxic ...... eatment of choroidal melanoma.

@nl

P1476

Comparative outcomes and toxic ...... eatment of choroidal melanoma.

@en

P2093

Arun Singh

http://www.w3.org/2001/XMLSchema#string

Caroline Craven

http://www.w3.org/2001/XMLSchema#string

Chris Bergstrom

http://www.w3.org/2001/XMLSchema#string

Ehsan Balagamwala

http://www.w3.org/2001/XMLSchema#string

Hans E Grossniklaus

http://www.w3.org/2001/XMLSchema#string

Hasan Danish

http://www.w3.org/2001/XMLSchema#string

Ian R Crocker

http://www.w3.org/2001/XMLSchema#string

Jeffrey M Switchenko

http://www.w3.org/2001/XMLSchema#string

John Suh

http://www.w3.org/2001/XMLSchema#string

Kirtesh R Patel

http://www.w3.org/2001/XMLSchema#string

P2860

Laser photocoagulation for radiation retinopathy after ophthalmic plaque radiation therapy

Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes.

Assessment of metastatic disease status at death in 435 patients with large choroidal melanoma in the Collaborative Ocular Melanoma Study (COMS): COMS report no. 15.

Incidence of noncutaneous melanomas in the U.S.

Proper method for calculating average visual acuity.

Whole body PET/CT for initial staging of choroidal melanoma.

(106)Ru plaque brachytherapy for uveal melanoma: factors associated with local tumor recurrence.

Uveal melanoma: trends in incidence, treatment, and survival.

Vision Loss Following Episcleral Brachytherapy for Uveal Melanoma: Development of a Vision Prognostication Tool.

The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: characteristics of patients enrolled and not enrolled. COMS Report No. 17.

P31

scholarly article

P356

10.1097/CMR.0000000000000420

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2018-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29303890

http://www.w3.org/2001/XMLSchema#string

P932

5828969

http://www.w3.org/2001/XMLSchema#string